Moderna’s stock fell 8% on Thursday after a report said the biotech company’s late-stage trial for a potential coronavirus vaccine will be delayed. CNBC’s Meg Tirrell reports. For more coronavirus live updates: Moderna’s stock fell by as much as 9.4%…